XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenue $ 43,073 $ 22,042 $ 11,131
Costs and expenses:      
Cost of revenue (excluding depreciation and amortization) 20,597 8,108 2,944
Research and development 136,827 92,321 43,978
Sales and marketing 28,395 18,270 8,385
General and administrative 71,055 50,722 35,966
Depreciation and amortization 18,654 10,375 5,604
Total operating costs and expenses 275,528 179,796 96,877
Loss from operations (232,455) (157,754) (85,746)
Gain (loss) on change in fair value of warrant liabilities (117,107) (19,206) 30,136
Interest income, net 18,249 19,322 7,093
Other income (expense), net (275) (85) 6
Loss before income tax expense (331,588) (157,723) (48,511)
Income tax benefit (expense) (59) (48) 0
Net loss $ (331,647) $ (157,771) $ (48,511)
Net loss per share attributable to common stockholders—basic $ (1.56) $ (0.78) $ (0.25)
Net loss per share attributable to common stockholders—diluted $ (1.56) $ (0.78) $ (0.25)
Weighted average shares used in computing net loss per share attributable to common stockholders—basic 213,029,365 202,576,492 197,727,642
Weighted average shares used in computing net loss per share attributable to common stockholders—diluted 213,029,365 202,576,492 197,727,642